Cargando…
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We performed a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011574/ https://www.ncbi.nlm.nih.gov/pubmed/36914665 http://dx.doi.org/10.1038/s41598-023-31055-3 |